Search
for
Sort by
Research 601–630 of 1000+
- Approaches to lifestyle management in polycystic ovary syndrome
- In vivo and in vitro exposure to free fatty acids induce increased androgen production in animal models: a potential pathogenic factor of the polycystic ovary syndrome
- Del "contexto expandido" a la mesa de negociación
- The pediatric origins of polycystic ovary syndrome
- The Clinical Manifestations of Polycystic Ovary Syndrome (PCOS) and The Treatment Options
- The role of correction of metabolic disorders in the treatment of androgenetic alopecia in women
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych]
- FETAL METABOLIC PROGRAMMING IN THE ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME
- Premature Adrenarche
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- A Systematic Review of the Potential Role of Cinnamomum spp. in Modulating Insulin Sensitivity and Hyperandrogenism in Polycystic Ovary Syndrome (PCOS)
- Severe Hyperandrogenemia and Insulin Resistance in a 12-Year-Old Girl
- Actualités du SOPK
- Androgen excess and post-reproductive health
- POLİKİSTİK OVER SENDROMU'NUN ALT GRUPLARINDA METABOLİK ÖZELLİKLER
- The pathophysiology of polycystic ovary syndrome
- Drug Therapy in Polycystic Ovarian Syndrome
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- Endocrine and Reproductive Effects of Polycystic Ovarian Syndrome
- Recent advances in the treatment of polycystic ovary syndrome
- Pharmacotherapy of polycystic ovary syndrome - an update
- Activation of nuclear factor κB in response to cream ingestion is related to ovarian androgen hypersecretion in polycystic ovary syndrome
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age
- Targeting Pharmacological and Nanotechnology Based Therapeutics for Management of Hirsutism: A Comprehensive State-of-the-Art
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Endocrine abnormalities in ring chromosome 11: a case report and review of the literature